DGAP-News: Immunic, Inc.
/ Key word(s): Conference
Immunic, Inc. to Participate in Industry and Investor Conferences in June NEW YORK, June 10, 2021 - Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced participation in the following industry and investor conferences in June: - June 14-18: BIO Digital (formerly BIO International Convention). Members of the company's business development team will host one-on-one partnering meetings during the conference. To schedule a meeting, please use the BIO Digital partnering portal at: www.bio.org/events/bio-digital/partnering. - June 16-17: JMP Securities Life Science Conference. Daniel Vitt, Ph.D., Chief Executive Officer and President of Immunic, will participate in a fireside chat on Thursday, June 17, at 11:30 am ET. A live audio webcast of the presentation will be available on the "Events and Presentations" section of Immunic's website at: ir.imux.com/events-and-presentations. An archived replay will be available on the company's website for a period of 90 days. About Immunic, Inc. Cautionary Statement Regarding Forward-Looking Statements Contact Information US IR Contact US Media Contact 10.06.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
1206237 10.06.2021